Nilsson, Erik http://orcid.org/0000-0001-8747-4759
Sandgren, Kristina http://orcid.org/0000-0001-8890-241X
Grefve, Josefine http://orcid.org/0000-0002-3488-7784
Jonsson, Joakim
Axelsson, Jan
Lindberg, Angsana Keeratijarut
Söderkvist, Karin http://orcid.org/0000-0002-3683-3763
Karlsson, Camilla Thellenberg http://orcid.org/0000-0002-7061-7255
Widmark, Anders
Blomqvist, Lennart
Strandberg, Sara http://orcid.org/0000-0002-0943-8178
Riklund, Katrine http://orcid.org/0000-0001-5227-8117
Bergh, Anders
Nyholm, Tufve http://orcid.org/0000-0002-8971-9788
Funding for this research was provided by:
Cancer Research Foundation in Northern Sweden (AMP 22-1089)
Cancerfonden (21 1594 Pj)
Article History
Received: 4 February 2023
Accepted: 26 October 2023
First Online: 9 November 2023
Competing interests
: C.T.K. has been on speakers bureau for Janssen, Astra Zeneca, Amgen and MSD. K.R is a board member of Collective Minds Radiology AB and an advisory board member of PCCT GE Healthcare. The remaining authors declare no competing interests.